Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.7 |
mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Panobinostat | FIMM | pan-cancer | AAC | 0.047 | 0.7 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.066 | 0.7 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |